ArticleTranslational pediatrics2026
Lactate dehydrogenase-to-albumin ratio as a predictor of coronary artery lesions in Kawasaki disease.
Article in Translational pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and internal validation of a monocyte-to-albumin ratio-based risk assessment model for coronary artery lesions in Kawasaki disease.Frontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The lactate dehydrogenase-to-albumin ratio (LAR), a novel marker reflecting systemic inflammation and nutritional status, was investigated for its association with coronary artery lesions (CALs) in Kawasaki disease (KD). Methods: A total of 231 pediatric patients with KD were stratified into the CAL group (n=35) and the non-CAL group (n=196). The CAL was defined based on the adjusted Z-score ≥2.0 of the coronary artery inner diameter according to body surface area. Demographic data and pre-treatment laboratory parameters were collected. Univariate analysis was used to screen for potential predictive factors, and multivariate logistic regression was used to analyze the influencing factors of KD complicated with CAL. The predictive performance was evaluated using the receiver operating characteristic (ROC) curve, and the area under the curve (AUC) was calculated. Results: Univariate analysis revealed that the CAL group exhibited younger age, and significantly elevated levels of LAR and lactate dehydrogenase and higher proportion of incomplete KD compared to the non-CAL group (all P<0.05). Multivariate analysis confirmed LAR [odds ratio (OR) =1.152] and incomplete KD (OR =4.268) were independent predictive factors of CAL in KD. In the subgroup analysis of complete KD, LAR was remained significantly associated with CAL (P<0.05). ROC curve analysis identified the combined AUC of LAR and incomplete KD was 0.719 [95% confidence interval (CI): 0.629-0.810] and an optimal LAR cutoff of 6.97 (AUC =0.671, sensitivity =80.00%, specificity =53.10%). For complete KD, the optimal LAR cutoff for predicting CAL was 7.00, with an AUC of 0.662 (95% CI: 0.557-0.768). Conclusions: LAR was an independent influencing factor for KD complicated with CAL. LAR could be utilized as an auxiliary diagnostic biomarker for CAL in KD, particularly in complete KD cases, offering a reference for precise KD management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.